Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines.
We examined the effects of various peroxisome proliferators (PPs) such as the hypolipidaemic agents clofibric acid (CLO), bezafibrate (BEZA), ciprofibrate (CIPRO) and nafenopin (NAFE) and the plasticizer di-(2-ethylhexyl)phthalate (DEHP) on peroxisomal enzyme activities, apoptosis and DNA synthesis in rat FaO and human HepG2 hepatoma cell lines. Both growing and confluent cultures were treated with PPs (250 microM) for 48 or 72 h. In accordance with our previous observations in PP-treated primary hepatocyte cultures of rat and human origin, the various PPs increased peroxisomal enzyme activities in rat FaO cells but not in human HepG2 cells. PPs strongly induced apoptosis in FaO cells. They did not affect TGFbeta-induced apoptosis, with the exception of DEHP and NAFE, respectively blocking and increasing induced apoptosis in confluent cultures. Moreover, PPs produced a minor, but significant, decrease in DNA synthesis in FaO cells. PPs also decreased DNA synthesis in growing HepG2 cells, and CLO, CIPRO and NAFE induced apoptosis in confluent HepG2 cultures. This is in opposition with the effects of PPs on primary hepatocyte cultures, i.e. inhibition of both spontaneous and TGFbeta-induced apoptosis and increases in DNA synthesis in rat hepatocytes, and unchanged mitosis-apoptosis balance in human hepatocytes.
Goll
V
V
Laboratoire de Biologie Cellulaire, Faculté de Médecine et de Pharmacie, Besançon, France.
Viollon-Abadie
C
C
Nicod
L
L
Richert
L
L
D042962:Acyl-CoA Oxidase; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D006528:Carcinoma, Hepatocellular / Q000201:enzymology / Q000473:pathology*; D002332:Carnitine O-Acetyltransferase / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects / Q000473:pathology; D004247:DNA / Q000096:biosynthesis*; D004261:DNA Replication / Q000187:drug effects*; D018197:Hepatoblastoma / Q000201:enzymology / Q000473:pathology*; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D008113:Liver Neoplasms / Q000201:enzymology / Q000473:pathology*; D010088:Oxidoreductases / Q000378:metabolism; D020025:Peroxisome Proliferators / Q000633:toxicity*; D020675:Peroxisomes / Q000187:drug effects / Q000201:enzymology; D051381:Rats; D016211:Transforming Growth Factor alpha / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D020025:Peroxisome Proliferators; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D004247:DNA; D010088:Oxidoreductases; D042962:Acyl-CoA Oxidase; D002332:Carnitine O-Acetyltransferase